Canonical and noncanonical TGF-β signaling regulate fibrous tissue differentiation in the axial skeleton

Sade W Clayton1, Ga I Ban1,2, Cunren Liu1

  • 1Department of Cell Developmental and Integrative Biology, University of Alabama at Birmingham, 660 MCLM, 1918 University Blvd., Birmingham, Al, 35294-0005, USA.

Scientific Reports
|December 8, 2020
PubMed

Insights

Transforming growth factor-beta (TGF-β) regulates fibrous connective tissue development in the spine. TGF-β signaling involves ERK1/2 and Scleraxis, with Smad3 cooperating to control Fibromodulin and Adamtsl2 expression.

Area of Science:

  • Developmental Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Transforming growth factor-beta (TGF-β) signaling is crucial for embryonic development.
  • Previous studies linked TGF-β type 2 receptor to fibrous connective tissue integrity in the spine.
  • The precise molecular mechanisms of TGF-β in sclerotome fibrous differentiation remain incompletely understood.

Purpose of the Study:

  • To elucidate the signaling pathways by which TGF-β regulates key fibrous matrix genes in the mouse sclerotome.
  • To identify the roles of canonical (Smad3) and noncanonical (ERK1/2) pathways in TGF-β-mediated gene expression.
  • To determine the potential involvement of Scleraxis as an intermediate in TGF-β signaling.

Main Methods:

  • Treatment of mouse sclerotome cells with TGF-β.
  • Quantitative analysis of Scleraxis, Fibromodulin, and Adamtsl2 mRNA expression.
  • Investigation of protein synthesis requirements using cycloheximide.
  • Assessment of Smad3 and ERK1/2 pathway involvement via genetic manipulation or inhibitors.
  • Analysis of gene expression in Smad3-deficient and ERK1/2-inhibited contexts.

Main Results:

  • TGF-β rapidly stimulated Scleraxis mRNA and, with a delay, Fibromodulin and Adamtsl2 mRNA.
  • Scleraxis regulation by TGF-β was protein synthesis-independent, while Fibromodulin and Adamtsl2 required it.
  • Scleraxis acts as an intermediate for TGF-β-induced Fibromodulin and Adamtsl2 expression.
  • ERK1/2 activation by TGF-β was essential for regulating all three fibrous markers.
  • Smad3 was not required for Scleraxis regulation but was necessary for Fibromodulin and Adamtsl2 expression.

Conclusions:

  • A novel TGF-β signaling cascade in sclerotome involves ERK1/2 activation leading to Scleraxis expression.
  • Scleraxis, in conjunction with Smad3, subsequently drives the expression of Fibromodulin and Adamtsl2.
  • This pathway defines a new mechanism for TGF-β in controlling fibrous differentiation during spine development.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
9.7K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.0K
Growth of Cartilage and Bone Tissue01:27

Growth of Cartilage and Bone Tissue

Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
3.8K
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.6K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.4K
Determination01:51

Determination

During embryogenesis, cells become progressively committed to different fates through a two-step process: specification followed by determination. Specification is demonstrated by removing a segment of an early embryo, “neutrally” culturing the tissue in vitro—for example, in a petri dish with simple medium—and then observing the derivatives. If the cultured region gives rise to cell types that it would normally generate in the embryo, this means that it is specified. In...
20.2K